Verrica Pharmaceuticals Inc (VRCA)
1.00
+0.01
(+1.01%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -332.0% |
| March 31, 2024 | -531.4% |
| December 31, 2023 | -1.24K% |
| September 30, 2023 | -850.3% |
| June 30, 2023 | -6.04K% |
| March 31, 2023 | -17.81K% |
| December 31, 2022 | -8.72K% |
| Date | Value |
|---|---|
| September 30, 2022 | 1.00% |
| June 30, 2022 | -4.75K% |
| March 31, 2022 | -1.97K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -7.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.81K%
Minimum
Mar 2023
1.00%
Maximum
Sep 2022
-3.84K%
Average
-1.24K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Elite Pharmaceuticals Inc | -58.45% |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | -54.71% |
| Terns Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.62K% |
| Return on Assets | -128.8% |
| Return on Invested Capital | -184.4% |
| Return on Net Operating Assets | -746.9% |